$247 Million is the total value of KNOTT DAVID M's 152 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FNMAP | New | Fannie Mae Float Series F | $1,507,000 | – | 81,890 | +100.0% | 0.61% | – |
| ALKS | New | Alkermes PLC | $879,000 | – | 43,073 | +100.0% | 0.36% | – |
| FNMAO | New | Fannie Mae Float - Series G | $393,000 | – | 22,477 | +100.0% | 0.16% | – |
| QURE | New | uniQure N.V. | $351,000 | – | 4,900 | +100.0% | 0.14% | – |
| New | Alimera Sciences, Inc. | $342,000 | – | 45,155 | +100.0% | 0.14% | – | |
| COLL | New | Collegium Pharmaceutical, Inc. | $257,000 | – | 12,500 | +100.0% | 0.10% | – |
| SBBP | New | Strongbridge Biopharma PLC | $209,000 | – | 100,000 | +100.0% | 0.08% | – |
| VLY | New | Valley National Bancorp | $143,000 | – | 12,480 | +100.0% | 0.06% | – |
| FMCKO | New | Freddie Mac 5.9 percent Series U | $100,000 | – | 10,000 | +100.0% | 0.04% | – |
| ASND | New | Ascendis Pharma A/S | $91,000 | – | 656 | +100.0% | 0.04% | – |
| BMYRT | New | Bristol-Myers Squibb Company - CVR | $48,000 | – | 15,847 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
| Pfizer Inc. | 34 | Q3 2021 | 17.4% |
| Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
| JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
| Apple Inc. | 34 | Q3 2021 | 2.1% |
| Microsoft Corporation | 34 | Q3 2021 | 2.3% |
| AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
| Johnson & Johnson | 34 | Q3 2021 | 0.6% |
| Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
| Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
| Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
| Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
| Westway Group, Inc. | February 01, 2013 | ? | ? |
| FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
| COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
| Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
| Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
| China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
| NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-12 |
| 13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.